category,datetime,headline,id,image,related,source,summary,url
company,1768855440,"Down 55%, Should You Buy the Dip on Pfizer?",138180931,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?",https://finnhub.io/api/news?id=90461fe2b10ef9c117a39ff656e5a36792ceef896cca2c913a981ad8f3b24764
company,1768854180,"Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All",138190298,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.",https://finnhub.io/api/news?id=57367d017880e4664e991c3a9622229984c34e45963c36c3e5766ccee9fb26e8
company,1768853400,Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance,138181758,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2236985195/image_2236985195.jpg?io=getty-c-w1536,PFE,SeekingAlpha,Invesco Equity And Income Fund's Q4 2025 report highlights strategic shifts toward AI-driven electronics and medical diagnostics. Read the full analysis now.,https://finnhub.io/api/news?id=8fa0e8a042c25f853ecd5bad09f8c876e3d807104ce7543c9a5c9a3a621af195
company,1768833076,"Congresswoman Violates STOCK Act With Over 200 Late Trade Disclosures: Purchases Include Mag7, Healthcare Stocks",138177907,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"Rep. Julia Letlow (R-La.) reportedly violated a federal transparency law by failing to disclose her personal stock trades within the required time frame. Lawmaker Missed STOCK Act Trade Filings Letlow, a third-term Louisiana congresswoman, failed to disclose 224 stock and bond trades within the 45-day reporting window required under the Stop Trading on Congressional Knowledge (STOCK) Act, reported NOTUS on Thursday. Letlow also amended all five of her annual financial disclosures dating back to",https://finnhub.io/api/news?id=52a86d894e854b8bc3ddce2e1a7b7ed746942a5921d3267cb29d669d7e0f95fb
company,1768832400,MoneyShow's Best Investment Ideas For 2026: Part 7,138179951,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153471752/image_2153471752.jpg?io=getty-c-w1536,PFE,SeekingAlpha,"MoneyShow presents top investment ideas for 2026 from leading advisors. Part 7 includes Pfizer, Philip Morris International, Platinum Group Metals, Prologis and QuickLogic Corp.",https://finnhub.io/api/news?id=482eab100e99dd982f175182032352444338ce002872fb679fd45a1f0e4f3bb1
company,1768831260,What to Expect From Pfizer's Non-Oncology Business in Q4?,138178028,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"PFE's Q4 outlook centers on Eliquis growth, softer COVID-19 sales and steady demand for key non-oncology drugs ahead of earnings.",https://finnhub.io/api/news?id=9d9a55221c7cabf25da1878a53208465bc3c6639f9dce083cc975a8e8e3eb4a8
company,1768813320,"AI in Drug Discovery Market Research Report 2026-2040: NVIDIA, Insilico Medicine, Google DeepMind, Pfizer, and Roche Leveraging AI Platforms to Accelerate Development Timelines and Reduce R&D Costs",138175720,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"AI in drug discovery offers key market opportunities by enhancing drug development efficiency, reducing costs, and improving success rates. It supports personalized medicine, facilitating custom therapies. The market will grow due to investments, collaboration, and AI's role in addressing rising chronic conditions.Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The ""AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Tr",https://finnhub.io/api/news?id=b550283fed8c2379bd057fdd19efb3af9179be0faf1ae9f00d9360c8b9293071
company,1768797673,1 Cash-Producing Stock Worth Your Attention and 2 That Underwhelm,138176350,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,PFE,Yahoo,"A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.",https://finnhub.io/api/news?id=9d842825b20436f44b0093a2ea31c53bcb7bbb2977ece838edeb27911a8ccd64
